NVAX logo

Novavax (NVAX) Accounts Receivable

Annual Accounts Receivable

$297.24 M
+$214.87 M+260.84%

December 31, 2023


Summary


Performance

NVAX Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNVAXbalance sheetmetrics:

Quarterly Accounts Receivable

$94.96 M
+$62.86 M+195.79%

September 30, 2024


Summary


Performance

NVAX Quarterly Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNVAXbalance sheetmetrics:

Accounts Receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

NVAX Accounts Receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+260.8%-23.2%
3 y3 years+13.4%-79.1%
5 y5 years+100.0%+100.0%

NVAX Accounts Receivable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-34.7%+260.8%-80.1%+344.2%
5 y5-year-34.7%+3863.2%-80.1%-100.0%
alltimeall time-34.7%-100.0%-80.1%-100.0%

Novavax Accounts Receivable History

DateAnnualQuarterly
Sep 2024
-
$94.96 M(+195.8%)
Jun 2024
-
$32.10 M(+50.2%)
Mar 2024
-
$21.38 M(-92.8%)
Dec 2023
$297.24 M(+260.8%)
$297.24 M(+140.4%)
Sep 2023
-
$123.66 M(-68.7%)
Jun 2023
-
$394.89 M(+249.9%)
Mar 2023
-
$112.85 M(+37.0%)
Dec 2022
$82.38 M(-81.9%)
$82.38 M(-26.2%)
Sep 2022
-
$111.64 M(-42.6%)
Jun 2022
-
$194.53 M(-59.3%)
Mar 2022
-
$478.16 M(+5.1%)
Dec 2021
$454.99 M(+73.7%)
$454.99 M(+504.4%)
Sep 2021
-
$75.28 M(+50.6%)
Jun 2021
-
$49.99 M(-12.1%)
Mar 2021
-
$56.90 M(-78.3%)
Dec 2020
$262.01 M(+3393.5%)
$262.01 M(+2020.7%)
Sep 2020
-
$12.36 M(>+9900.0%)
Jun 2020
-
$0.00(0.0%)
Mar 2020
-
$0.00(-100.0%)
Dec 2019
$7.50 M(>+9900.0%)
$7.50 M(>+9900.0%)
Dec 2018
$0.00(-100.0%)
$0.00(-100.0%)
Sep 2016
-
$591.00 K(+62.8%)
Jun 2016
-
$363.00 K(-10.6%)
Mar 2016
-
$406.00 K(-82.5%)
Dec 2015
$2.32 M(-69.1%)
$2.32 M(+5.6%)
Sep 2015
-
$2.20 M(-6.2%)
Jun 2015
-
$2.34 M(-64.9%)
Mar 2015
-
$6.67 M(-11.1%)
Dec 2014
$7.51 M(+293.0%)
$7.51 M(+162.7%)
Sep 2014
-
$2.86 M(-23.1%)
Jun 2014
-
$3.72 M(-16.7%)
Mar 2014
-
$4.47 M(+133.7%)
Dec 2013
$1.91 M(+89.0%)
$1.91 M(0.0%)
Sep 2013
-
$1.91 M(+110.7%)
Jun 2013
-
$907.00 K(-65.1%)
Mar 2013
-
$2.60 M(+157.4%)
Dec 2012
$1.01 M
$1.01 M(-59.1%)
Sep 2012
-
$2.47 M(+64.8%)
Jun 2012
-
$1.50 M(-13.2%)
DateAnnualQuarterly
Mar 2012
-
$1.73 M(-12.2%)
Dec 2011
$1.97 M(+3538.9%)
$1.97 M(>+9900.0%)
Sep 2011
-
$17.00 K(-99.1%)
Jun 2011
-
$1.83 M(-27.2%)
Mar 2011
-
$2.52 M(+4561.1%)
Dec 2010
$54.00 K(-79.1%)
$54.00 K(-91.0%)
Sep 2010
-
$599.00 K(+68.3%)
Jun 2010
-
$356.00 K(+54.1%)
Mar 2010
-
$231.00 K(-10.5%)
Dec 2009
$258.00 K(-79.7%)
$258.00 K(-21.8%)
Sep 2008
-
$330.00 K(+0.9%)
Jun 2008
-
$327.00 K(-49.5%)
Mar 2008
-
$647.00 K(-59.6%)
Sep 2007
-
$1.60 M(+103.4%)
Jun 2007
-
$787.00 K(-13.1%)
Mar 2007
-
$906.00 K(-28.9%)
Dec 2006
$1.27 M(-64.3%)
$1.27 M(-59.2%)
Sep 2006
-
$3.13 M(-18.3%)
Jun 2006
-
$3.83 M(+6.2%)
Mar 2006
-
$3.60 M(+0.8%)
Dec 2005
$3.57 M(+331.8%)
$3.57 M(+211.3%)
Sep 2005
-
$1.15 M(+1.2%)
Jun 2005
-
$1.13 M(+81.0%)
Mar 2005
-
$626.00 K(-24.3%)
Dec 2004
$827.00 K(-57.8%)
$827.00 K(-53.5%)
Sep 2004
-
$1.78 M(-46.0%)
Jun 2004
-
$3.30 M(+42.3%)
Mar 2004
-
$2.32 M(+18.3%)
Dec 2003
$1.96 M(+4.1%)
$1.96 M(-31.5%)
Sep 2003
-
$2.86 M(+52.8%)
Jun 2003
-
$1.87 M(+47.3%)
Mar 2003
-
$1.27 M(-32.5%)
Dec 2002
$1.88 M(-51.5%)
$1.88 M(+24.3%)
Sep 2002
-
$1.51 M(-53.7%)
Jun 2002
-
$3.27 M(-16.1%)
Mar 2002
-
$3.90 M(+0.6%)
Dec 2001
$3.88 M
$3.88 M(+28.8%)
Sep 2001
-
$3.01 M(+20.7%)
Jun 2001
-
$2.50 M(+44.6%)
Mar 2001
-
$1.73 M

FAQ

  • What is Novavax annual accounts receivable?
  • What is the all time high annual accounts receivable for Novavax?
  • What is Novavax annual accounts receivable year-on-year change?
  • What is Novavax quarterly accounts receivable?
  • What is the all time high quarterly accounts receivable for Novavax?
  • What is Novavax quarterly accounts receivable year-on-year change?

What is Novavax annual accounts receivable?

The current annual accounts receivable of NVAX is $297.24 M

What is the all time high annual accounts receivable for Novavax?

Novavax all-time high annual accounts receivable is $454.99 M

What is Novavax annual accounts receivable year-on-year change?

Over the past year, NVAX annual accounts receivable has changed by +$214.87 M (+260.84%)

What is Novavax quarterly accounts receivable?

The current quarterly accounts receivable of NVAX is $94.96 M

What is the all time high quarterly accounts receivable for Novavax?

Novavax all-time high quarterly accounts receivable is $478.16 M

What is Novavax quarterly accounts receivable year-on-year change?

Over the past year, NVAX quarterly accounts receivable has changed by -$28.70 M (-23.21%)